Abstract
There is randomised study evidence that narrowband ultraviolet B (NB-UVB) is effective for eczema. A small controlled study did not detect an efficacy difference between bath 8-MOP PUVA (psoralen drug with the main effects limited to the skin as the drug is 'activated' there by ultraviolet A [UVA] exposure) and NB-UVB. Another small randomised study showed that 5-MOP oral PUVA worked better than medium-dose ultraviolet A1 (UVA1). A systematic review concluded that NB-UVB and ultraviolet A1 were the most effective phototherapies for eczema and pointed out the limited comparative evidence regarding PUVA.
| Original language | English |
|---|---|
| Pages (from-to) | 153-156 |
| Number of pages | 4 |
| Journal | Photodermatology, Photoimmunology & Photomedicine |
| Volume | 37 |
| Issue number | 2 |
| Early online date | 23 Sept 2020 |
| DOIs | |
| Publication status | Published - Mar 2021 |
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology
- Radiology Nuclear Medicine and imaging
- Dermatology
Fingerprint
Dive into the research topics of 'A retrospective review of factors associated with response to phototherapy and PUVA for atopic eczema'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver